The conclusion that the lateral interactions via domains 2 and 3 can adjust the trans-interactions to facilitate axo-dendritic contacts and presynaptic induction is drawn from overexpression experiments. It is therefore not clear if the observed reduced trans-interaction by overexpressing Ig2+3-GPI is due to a dominant negative effect of sequestering the available full length SynCAM extracellular region carrying the Ig domain 1, or because of truly compromising the strength of trans-interactions by reducing the available lateral interactions between SynCAM that participate in trans-binding. Additional experimental evidence is needed in support of the conclusion. For example, one should test whether the ability for SynCAM to recruit presynaptic assembly is attenuated by extracellular addition of soluble domains 2 and/or 3 of SynCAM, without relying on overexpression.
Fig. 1. The conclusion that the SynCAM being imaged is present on a dendrite would be more compelling with double labelling for dendritic marker proteins.
Rather than citing their previous PNAS paper, one should explicitly state that pHluorin-SynCAM is functional and that it rescues the SynCAM KO phenotype. Fig. 5 . Here the authors analyze the role of SynCAM1 cis interactions in recruiting SV2 to neuronal contacts using co-cultures system. As SynCAM1 is present at both sides of the synapse it would be informative to determine whether SynCAM1 cis interactions also promote the formation of postsynaptic specializations at excitatory and inhibitory synapses (e.g. examining for PSD-95 vs. gephyrin). Fig. 6 . Based on monitoring of SV2 puncta size, the authors conclude that "Postsynaptic SynCAM1 self-assembly therefore restricts the size of presynaptic terminals". However, SV2 labeling is a measure of synaptic vesicle protein abundance, and at best, it could reflect the size of the synaptic vesicle pool but not the size of the synaptic structure itself. For instance, SynCAM1 could be increasing the number of synaptic vesicles per bouton without necessarily affecting synaptic structure. One needs to test for additional parameters, such as the presynaptic active zone and the PSD proteins. An ultrastructural analysis would be the most direct way to look for a change in structure.
Abstract: It is not clear what is meant by "the patterning of the synaptic cleft". No data are shown in support of such a statement. Also, the statement that SynCAM complexes "shape synapses" needs to be more specific --i.e. "restrict the size of presynaptic vesicle clusters (and "the size of the adhesive contact area" if the authors could show that this is indeed the case).
Referee #2 (Remarks to the Author):
The manuscript by Fogel and coworkers provides biochemical and cell biological evidence for SynCAM 1 interacting with other SynCAM 1 monomers in cis. Interfering with this self-assembly by co-expression of Ig domains 2+3 of SynCAM 1 reduces the adhesive strength towards soluble SynCAM 2-Fc fusion protein. Using this dominant-interfering approach the authors then go on to implicate SynCAM 1 self-assembly in endogenous SynCAM 1 clustering in cultured neurons, in synapse induction in neuron/COS cell co-cultures and in the size of presynaptic terminals.
Overall the study is quite interesting and addresses an important mechanistic question. The study is technically well executed and written. However, the results are preliminary and not yet convincing. Figure 1A ,B would only be useful, if the authors supplied a control demonstrating that the signals they detect are indeed only SynCAM 1 (by using SynCAM 1 KO cells) and if they provide some evidence that immobile SynCAM 1 clusters consist of homodimers and oligomers (by interfering with self-assembly or promoting self-assembly) thereby excluding that SynCAM 1 is simply bound to some other immobile cellular protein.
The data in
2. Figure 2E ,F shows FRET between full-length SynCAM 1 and Ig domains 2+3, indicating the formation of mixed clusters. Since this dominant-interfering approach is used extensively for subsequent functional assays, the authors need to demonstrate that this approach interferes with SynCAM 1 self-assembly in co-transfected cells and in neurons. Ideally, the authors should come up with an independent way of interfering with SynCAM 1 self-assembly (an interfering peptide that can be added acutely to the cells or alike).
3. Co-expression of full-length SynCAM 1 and Ig domains 2+3 reduces binding of soluble SynCAM 2-Fc fusion protein to the cells. I would like to see evidence that this approach affects SynCAM 1-mediated cell-cell adhesion as well. Cell-cell adhesion is much more relevant for the subsequent analysis of synapse formation. Figure 4 is not convincing. More controls are needed (e.g. co-expression of a mutant Ig domains 2+3 construct that fails to interact with endogenous SynCAM 1). Moreover, the results are over interpreted. The readout of the data is SynCAM clustering not 'adhesive assembly'. Figure 6 is not convincing either. Higher power images are required for the reader to appreciate the results. Co-localization (or lack of) of Ig domains 2+3 with presynaptic markers should be shown.

6. The story would be much more convincing, if the authors provided complementary evidence that the promotion of SynCAM 1 self-assembly leads to opposite effects on cell-cell adhesion, synapse formation and size. 
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Referee #1:
We appreciate the reviewer's conclusions that this study addresses a "timely topic that should be of general interest to the EMBO J readership" and that the experiments are of "high technical quality". We also thank the reviewer for her/his comments. These guided us to perform new experiments that further support the conclusions of this study and helped to increase the clarity of the text. Specifically, we have performed two key experiments in response to the reviewer. Our results show that addition of the soluble Ig2+3 protein abrogates the synaptogenic activity of SynCAM 1 (new Figure 6C ,D) and that the neuronal expression of the Ig2+3-GPI protein enlarges the size of postsynaptic Shank puncta (new Figure 7A ,B). As suggested, we have additionally determined that the SynCAM 1 clusters in young neurons are on dendrites (new Figure 1A) . We now also report that the expression of Ig2+3-GPI does not affect adhesion-independent activities of SynCAM 1 (see Results, page 8). Our answers to the reviewer's comments are described in the point-by-point response below. The reviewer's original comments are shown in italics. Figure 6C ,D and described on page 9. In the Results section, we state that this finding indicates that the Ig2+3 protein interferes with lateral SynCAM interactions to reduce trans-synaptic interactions.
First major point: "The conclusion that the lateral interactions via domains 2 and 3 can adjust the trans-interactions to facilitate axo-dendritic contacts and presynaptic induction is drawn from overexpression experiments. It is therefore not clear if the observed reduced trans-interaction by overexpressing Ig2+3-GPI is due to a dominant negative effect of sequestering the available full length SynCAM extracellular region carrying the Ig domain 1, or because of truly compromising the strength of trans-interactions by reducing the available lateral interactions between
A second set of new experiments also relates to the reviewer's point. Previously, we have shown that SynCAM 1 down-regulates the number of filopodia on migrating growth cones (Stagi et al. (2010) PNAS 107: 7568; Fig.3E ). We have now found that overexpression of Ig2+3 GPI does not alter this activity of SynCAM 1. This finding is now stated in the Results section on page 8. This result supports a specific reduction of adhesion-dependent functions of SynCAM by Ig2+3 GPI overexpression rather than a general, nonspecific effect on SynCAM 1. Point on Fig. 1 : "The conclusion that the SynCAM being imaged is present on a dendrite would be more compelling with double labelling for dendritic marker proteins."
We have now used immunostaining to label both surface SynCAM 1 and the dendritic marker MAP2 in dissociated neuron cultures at 5 d.i.v. Our results support that SynCAM 1 is present in surface clusters along MAP2-positive dendrites. This is now shown in the new Figure 1A , which replaces the previous Figure 1A that had only shown a staining for SynCAM 1.
Point on the Results section: "Rather than citing their previous PNAS paper, one should explicitly state that pHluorin-SynCAM is functional and that it rescues the SynCAM KO phenotype. "
While our paper Stagi et al. (2010) shows that SynCAM 1-pHluorin is expressed on growth cones and at synapses like the endogenous protein (Stagi et al., Figs.1D and S8) , that it is functional as it regulates growth cone dynamics (Stagi et al., Fig.3E,F) , and that axo-dendritic contact induces its adhesive assembly (Stagi et al., Fig.2A-F Fig.1E ). Our own preliminary studies support this conclusion. We therefore would like to refer the reviewer's question to this published study, and have included this reference in the revised Introduction on page 3. Point on Fig. 6 Please note that the comments below refer to Figure 7 of the revised manuscript. We have now corrected the Results and the legend of Figure 7C ,D to state that postsynaptic expression of Ig2+3-GPI enlarges the area occupied by presynaptic vesicles. No reference to presynaptic terminal size is made in the revised text.
Further, we now include an additional parameter in this analysis. New quantitative immunostainings of mature neurons at 21 d.i.v. demonstrate a significant 59 ± 19% increase in puncta area of the postsynaptic marker Shank upon dendritic expression of Ig2+3-GPI. These data are now described on page 10 and are shown in the new Figure 7A ,B. They support that postsynaptic interactions of the SynCAM Ig2+3 domains can modulate pre-and postsynaptic morphological properties. This is consistent with our previously reported result that the loss of SynCAM 1 shortens pre-and postsynaptic specializations in vivo (Robbins et al (2010) Neuron 68: 894).
We have also changed the representation of the data from these quantitated immunostainings. The information on average puncta area previously shown as bar graphs is now provided in the text of the Results section. Figure 7 additionally represents the cumulative frequency distribution of these data points to allow the assessment of size changes across all puncta populations. 
if the authors could show that this is indeed the case). "
The statement that SynCAM "patterns" the synaptic cleft was removed and replaced with the statement that this protein can contribute to the structural organization of synaptic sites. Further, the statements in the original submission that synaptic adhesion and SynCAM molecules play roles in "shaping synapses" were replaced with the more specific point that lateral interactions of SynCAM can modulate synaptic morphological parameters.
Referee #2: We appreciate that the reviewer concludes that our study of SynCAM self-assembly addresses an "important mechanistic question" and is "technically well executed". We also thank her/him for suggesting additional experiments to further strengthen this study. Guided by the reviewer's comments, we have developed a new approach of interfering with SynCAM 1 assembly using a soluble fusion protein comprised of the Ig2+3 domains (new Figure 3) . Following the additional suggestions, we now also show that the SynCAM 1 staining observed in this study is specific (new Figure 1A) and that the Ig2+3-GPI construct used in this study sorts to synaptic sites (new Supplemental Figure 4 ). These new experiments support and extend our previous conclusions. In addition, we have clarified the presentation of some results. Below are our detailed responses to each point. The reviewer's original comments are shown in italics.
Point 1: "The data in Figure 1A, To address the first point, we have performed as suggested new SynCAM 1 immunostainings of dissociated wild-type and SynCAM 1 KO neurons. Our results show that the live labeling method employed in Figure 1A yields a highly specific staining of SynCAM 1 clusters that is lost in the KO neurons. The results from these new control experiments are shown in the revised Figure 1A and replace the previous data set.
Regarding the composition of the immobile SynCAM 1-pHluorin clusters in Figure 1B , we followed the reviewer's idea and interfered with SynCAM self-assembly by adding a soluble Ig2+3 fusion protein to the live neurons. This reduced the number of SynCAM 1 clusters, and the remaining clusters are smaller (see the new Figure 3) . These results support that SynCAM 1 clusters consist of oligomers that are maintained by Ig2+3 interactions.
Point 2: "Figure 2E,F shows FRET between full-length SynCAM 1 and Ig domains 2+3, indicating the formation of mixed clusters. Since this dominant-interfering approach is used extensively for subsequent functional assays, the authors need to demonstrate that this approach interferes with SynCAM 1 self-assembly in co-transfected cells and in neurons. Ideally, the authors should come up with an independent way of interfering with SynCAM 1 self-assembly (an interfering peptide that can be added acutely to the cells or alike)."
We have developed as described above a new approach to interfere with laterally assembled SynCAM 1 clusters that is based on treating neurons with a purified, soluble Ig2+3 protein (see the new Figure 3) . We have also employed this new interfering approach to analyze effects of the soluble Ig2+3 protein on the synaptogenic activity of SynCAM 1. Our experiments show that this treatment abrogates the synapse-inducing activity of SynCAM 1 (see the new Figure 6C,D) . These results support and extend the use of Ig2+3 interfering approaches for our functional studies. Figure 6A ,B provides evidence that expression of Ig2+3 affects SynCAM-mediated adhesive interactions, which supports the results from our binding assays in Figure 4 . Specifically, Figure  6A ,B shows that the co-expression of Ig2+3 with SynCAM 1 in non-neuronal cells reduces the ability of SynCAM 1 to recruit neuronal SynCAMs to the contacts of these non-neuronal cells with neurons. This is consistent with a reduction in SynCAM-mediated cell adhesion by the Ig2+3 construct.
We have additionally aimed to address the reviewer's question using an assay that visualizes adhesive SynCAM contacts between cells (Fogel et al 2007 J Neurosci 27:12516; Fig.6B ). However, we found that this assay is not suitable as it only determines whether interactions occur, but does not allow for the comparison of interaction strength. We therefore hope that the reviewer agrees that the data provided in this manuscript sufficiently support that the expression of Ig2+3 reduces adhesive SynCAM binding. Please note that the comments below refer to Figure 5 of the revised manuscript. We thank the reviewer for helping us to clarify our data presentation, and now state on page 7 that these experiments measure the clustering of SynCAM 1 that is initiated by growth cone contact with a neurite. The interpretation that this contact-induced accumulation corresponds to 'adhesive assembly' is based on our previous finding that this clustering requires the Ig1 domain of SynCAM 1, which is necessary for cell adhesion (see Stagi et al. (2010) 107: 7568; Fig.2D,E) . We now provide this information on page 7.
Further, our use of the Ig2+3 construct to interfere with contact-induced SynCAM clustering in Figure 5 relies on our findings that (i) Ig2+3 GPI assembles laterally with SynCAM 1 in live cells ( Figure 2E ), (ii) addition of the Ig2+3 protein to live neurons disrupts SynCAM 1 clusters (new Figure 3) , (iii) Ig2+3 GPI reduces the ability of SynCAM 1 to retain its adhesive SynCAM partners ( Figures 4A,B and 6A,B) , (iv) the Ig2+3 GPI construct does not alter the surface expression of SynCAM 1 (Supplementary Figure 3) , and (v) our new finding that Ig2+3 GPI does not exert a general, non-specific negative effect on SynCAM 1 activities (see our response to reviewer 3, point 1). The reviewer's suggestion to develop a mutant Ig2+3 construct that fails to interact with SynCAM 1 would provide for another interesting negative control, but the structural information necessary to design such a construct is not yet available. We therefore hope that the previously included controls and the new findings are sufficiently strong to interpret these data. We agree with the reviewer that this is an interesting question. Indeed, the overexpression of SynCAM 1 in cultured neurons and in vivo results in the phenotypes the reviewer predicts, i.e. strong adhesive interactions and more synapse formation (Fogel et al 2007 J Neurosci 27:12516; Robbins et al 2010 Neuron 68: 894) . Further, we observe similar effects after overexpression of the membrane-anchored SynCAM 1 extracellular domain (see Figure 6A ,B of this manuscript). These data are consistent with an increase in SynCAM 1 activity under overexpression conditions, which
